Position in ORGO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$45,715
+$418 QoQ
Shares Held
18,813
-1.6% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#77
of 135 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ORGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Capital Square, LLC holds $261,160 across 3 Drug Manufacturers - Specialty & Generic names. ORGO ranks #2 (17.5% of the industry book) .
All Filings in ORGO
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,715 | 18,813 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $45,297 | 19,113 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $55,985 | 10,808 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $71,782 | 17,010 | Shares | Sole | 2025-11-21 | |
| 2025-06-30 | $82,350 | 22,500 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $99,792 | 23,100 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $72,320 | 22,600 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $58,916 | 20,600 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $56,840 | 20,300 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $57,510 | 20,250 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $83,640 | 20,450 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $52,533 | 16,520 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||